FIGURE 1.
The association between TP53 status and clinical data. (A) KM survival analysis evaluated the relationship between TP53 status and PFS of patients in the MSKCC-LUAD cohort, p < 0.05. (B) Relationship between TP53 status and DFS of patients in the TCGA-LUAD cohort. DFS, disease-free survival. (C) Relationship between TP53 status and OS of patients in the TCGA-LUAD cohort. OS, overall survival. The log-rank test was used for a two-sided test, and P < 0.05 was regarded as significantly different.